Pi Pharma Intelligence Launches HTA Path Service to Help Companies Make Informed Decisions

In a bid to improve healthcare decision-making, Pi Pharma Intelligence has announced the launch of new HTA Path Service. The service is designed to streamline the healthcare technology assessment process by providing a comprehensive analysis of the benefits and risks of new technologies. The HTA Path Service will be available to healthcare providers and pharmaceutical companies helping them to make informed decisions about which technologies to adopt. The service will provide a detailed analysis of the clinical and economic impact of new technologies. The HTA Path Service will be available immediately, and the company expects strong demand from healthcare providers and industry leaders seeking to make data-driven decisions about the technologies they use.